Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...
Stomach pain is a common side effect of Wegovy (semaglutide) that affects approximately 20% of patients in clinical trials. This discomfort usually occurs because the medication slows down gastric ...
Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...
For decades, researchers have been looking for an effective weight-loss pill. But the recent success of glucagon-like peptide-1 (GLP-1) weight-loss injections has sparked new hope — especially for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results